image
Healthcare - Biotechnology - NASDAQ - GB
$ 3.62
-25.9 %
$ 2.1 M
Market Cap
-0.05
P/E
BALANCE SHEET
10.5 M ASSETS
90.81%
5.86 M LIABILITIES
148.16%
4.68 M EQUITY
47.94%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Biodexa Pharmaceuticals Plc
image
Current Assets 7.03 M
Cash & Short-Term Investments 5.97 M
Receivables 0
Other Current Assets 1.06 M
Non-Current Assets 3.51 M
Long-Term Investments 0
PP&E 571 K
Other Non-Current Assets 2.94 M
Current Liabilities 5.57 M
Accounts Payable 314 K
Short-Term Debt 169 K
Other Current Liabilities 5.09 M
Non-Current Liabilities 295 K
Long-Term Debt 295 K
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
ASSETS
Cash & Cash Equivalents 6.0 2.8 10.1 7.5 10.9 2.3 13.2 17.6 16.2 30.3 2.4 0.1
Short Term Investments 0 0 0 0 0 0 0 0 0 0 0 0
Receivables 0 0.3 33 K 95 K 22 K 89 K 2.2 1.4 1.0 0.2 0.2 0
Inventory 0 1 1 (1.4) 1 0 0.9 0.8 0.5 0 0 0
Other Current Assets 0.4 0.4 0.6 0.3 2.8 3.2 2.2 2.5 2.7 1.1 1.5 1.0
Total Current Assets 7.0 4.7 11.8 9.3 13.7 5.6 18.6 22.3 20.3 31.6 4.1 1.1
PP&E 0.6 0.8 1.2 0.5 2.2 2.0 2.5 2.8 2.0 1.5 0.7 0.9
Intangible Assets 2.9 6 K 0 0 10.1 10.1 14.2 16.7 28.9 10.8 4 K 2 K
Goodwill 0 0 0 0 2.3 2.3 13.4 14.5 12.5 2.3 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0 0 12 K 49 K
Other Long Term Assets 0 (0.8) (1.2) (0.5) 2.6 0.5 0.5 0.4 0.4 0.4 0.4 (0.9)
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0.2
Total Assets 10.5 5.5 12.9 9.8 30.9 20.4 49.2 56.7 64.0 46.7 5.2 2.2
LIABILITIES
Accounts Payable 0.3 0.3 0.5 0.3 0.7 0.3 2.3 3.3 2.3 1.0 0.5 0.6
Short Term Debt 0.2 0.2 0.1 0.2 0.4 0.4 0.4 0.5 0.4 0.5 1.2 0
Other Current Liabilities 5.0 1.3 1.2 2.4 4.4 1.8 5.7 5.5 6.4 1.4 0.6 4.5
Total Current Liabilities 5.6 1.9 1.8 3.0 5.7 2.5 8.4 9.3 9.1 2.8 2.3 5.1
Long Term Debt 0.3 0.5 0.6 60 K 5.7 0.9 6.2 1.6 1.5 1.5 2.1 2.2
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 0 0 469 50 K 0 0.2 0 0 6.5 0.4 0 (2.2)
Total Liabilities 5.9 2.4 2.5 3.1 11.3 3.5 14.5 11.0 17.2 4.7 4.4 7.3
EQUITY
Common Stock 1.2 1.1 98.5 K 63 K 23 K 3 K 3 K 2 K 2 K 1 K 0 0
Retained Earnings (144.8) (135.3) (127.8) (122.4) (99.8) (89.7) (74.7) (59.1) (39.2) (29.2) (20.4) (17.2)
Other Accumulative Comprehensive Income/Loss 61.5 53.0 53.0 53.0 53.5 53.7 56.4 57.6 54.4 39.6 0.1 0
Total Equity 4.7 3.2 10.5 6.7 19.6 16.9 34.7 45.7 46.9 42.0 0.8 (5.1)
Total Liabilities and Equity 10.5 5.5 12.9 9.8 30.9 20.4 49.2 56.7 64.0 46.7 5.2 0
SHARES OUTSTANDING
Common Shares Outstanding 31.6 K 12.4 K 10.1 K 5.36 K 2.29 K 0 0 0 0 0 0 0